Low Dose Decitabine | List of Frontiers open access articles

Original Research

Published on 15 Mar 2021

Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ+ CD4+ T Cells Through Enhancing IκBα Degradation and NF-κB Activation

in Cell Growth and Division

Xiang Li
Liang Dong
Jiejie Liu
Chunmeng Wang
Yan Zhang
Qian Mei
Weidong Han
Ping Xie
Jing Nie

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2021.647713

6,073 views
15 citations

Original Research

Published on 13 Jul 2021

Predictive Value of High ICAM-1 Level for Poor Treatment Response to Low-Dose Decitabine in Adult Corticosteroid Resistant ITP Patients

in Autoimmune and Autoinflammatory Disorders

Chaoyang Li
Lizhen Li
Meng Sun
Jianzhi Sun
Linlin Shao
Miao Xu
Yu Hou
Jun Peng
Lin Wang
Ming Hou

Frontiers in Immunology

doi 10.3389/fimmu.2021.689663

4,906 views
10 citations

Clinical Trial

Published on 16 Aug 2021

Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Jia Liu
Zhong-Xing Jiang
Xin-Sheng Xie
Ding-Ming Wan
Wei-Jie Cao
Meng Wang
Zhen-Zhen Liu
Zhen-Kun Dong
Hai-Qiong Wang
Run-Qing Lu

Frontiers in Oncology

doi 10.3389/fonc.2021.710545

5,523 views
18 citations

Original Research

Published on 17 Feb 2021

Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction via Modulating PD-1 Methylation in Immune Thrombocytopenia

in Autoimmune and Autoinflammatory Disorders

Panpan Han
Tianshu Yu
Yu Hou
Yajing Zhao
Yang Liu
Yunqi Sun
Haoyi Wang
Pengcheng Xu
Guosheng Li
Tao Sun

Frontiers in Immunology

doi 10.3389/fimmu.2021.630693

8,351 views
38 citations

Case Report

Published on 22 Oct 2020

Case Report: Low-Dose Decitabine Plus Anti-PD-1 Inhibitor Camrelizumab for Previously Treated Advanced Metastatic Non-Small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Xin Yan
Yongtian Zhao
Yang Liu
Qingming Yang
Liang Dong
Zhiqiang Wu
Jing Nie
Deyun Chen
Miaomiao Bai
Dongdong Ti

Frontiers in Oncology

doi 10.3389/fonc.2020.558572

5,866 views
18 citations

Clinical Trial

Published on 23 Feb 2021

Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimen: A Pilot Phase II Study

in Gene and Cell Therapy

Ling Wang
Li-ning Wang
Ji-fang Zhou
Wen-hui Gao
Chuan-he Jiang
Wei Tang
Wei-li Zhao
Jiong Hu
Jie-ling Jiang

Frontiers in Medicine

doi 10.3389/fmed.2021.627946

5,381 views
7 citations

Original Research

Published on 19 Jan 2023

Combination of single-cell and bulk RNA seq reveals the immune infiltration landscape and targeted therapeutic drugs in spinal cord injury

in Multiple Sclerosis and Neuroimmunology

Qing Zhang
Beibei Yu
Yongfeng Zhang
Yunze Tian
Shijie Yang
Yongfeng Chen
Haining Wu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1068359

23,255 views
36 citations

Articles

Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ+ CD4+ T Cells Through Enhancing IκBα Degradation and NF-κB Activation

Predictive Value of High ICAM-1 Level for Poor Treatment Response to Low-Dose Decitabine in Adult Corticosteroid Resistant ITP Patients

Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia

Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction via Modulating PD-1 Methylation in Immune Thrombocytopenia

Case Report: Low-Dose Decitabine Plus Anti-PD-1 Inhibitor Camrelizumab for Previously Treated Advanced Metastatic Non-Small Cell Lung Cancer

Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimen: A Pilot Phase II Study

Combination of single-cell and bulk RNA seq reveals the immune infiltration landscape and targeted therapeutic drugs in spinal cord injury